Skip to main content
. 2021 Jan 6;21:18. doi: 10.1186/s12872-020-01832-3

Table 2.

Proportion of patients experiencing negative relevant outcomes within 2 years after AMI

DMP only
N = 83
CR only
N = 451
Both
N = 189
None
 N = 371
Total
N = 1094
MACE1 45.8 14.6 19.1 27.5 22.1
35.0–57.1 11.5–18.2 13.7–25.4 23.0–32.3 19.7–24.7
MACE2 51.8 24.6 31.2 35.0 31.4
40.6–62.9 20.7–28.9 24.6–37.8 30.2–40.1 28.6–34.2
Reinfarction 10.8 8.9 7.4 10.2 9.2
5.1–19.6 6.4–11.9 4.1–12.1 7.4–13.8 7.6–11.1
Stroke 1.2 3.3 2.7 3.0 2.9
0.0–6.5 1.9–5.4 0.9–6.1 1.5–5.2 2.0–4.1
PCI 9.6 8.7 11.1 10.0 9.6
4.3–18.1 6.1–11.2 7.0–16.5 7.1–13.5 7.9–11.5
CABG 0.0 5.8 5.8 3.0 4.4
0.0–4.3 3.8–8.3 2.5–9.2 1.5–5.2 3.3–5.8
Cardiac death 13.3 0.7 2.7 5.7 3.7
6.8–22.5 0.1–1.9 0.9–6.1 3.5–8.5 2.6–5.0
Death (other) 25.3 2.9 9.0 11.3 8.5
16.4–36.0 1.5–4.9 5.3–14.0 8.3–15.0 6.9–10.3

MACE 1 = composite endpoint including Reinfarction, Stroke and Death (cardiac / other), MACE 2 = composite endpoint including MACE 1 plus percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG)

DMP disease management program, CR cardiac rehabilitation